New advances transform the management of women with abnormal Pap tests

Cleveland Clinic Journal of Medicine

Volumn 70, Issue 7, 2003, Pages 641-648

  Jin, Xian Wen ^a   Brainard, Jennifer ^a   Nielsen, Craig ^a   Yen Lieberman, Belinda ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE;

ARTICLE; COLPOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DNA DETERMINATION; FEMALE; HUMAN; NOMENCLATURE; PAPANICOLAOU TEST; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

EID: 0042591713     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.70.7.641     Document Type: Article

References (25)

1. Wright TC, Ferenczy A, Kuman RJ. Carcinoma and other tumors of the cervix. In: Kurman RJ, ed. Pathology of the Female Genital Tract. 4th ed. New York: Springer Verlag; 1994:279-326.
2. Center for Disease Control and Prevention. www.cdc.gov/nccdphp/brf-ss/index.htm.
3. National Cancer Institute. Cervical Cancer Screening - Health Professionals. www.cancer.gov. May 2002.
4. Devesa SS, Silverman DT, Young JL, et al. Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst 1987; 79:701-770.
5. National Cancer Institute. Cancer Statistics Review 1973-1987. 1990 Bethesda, MD. Report No.: NCI Pub. No. (NIH) 90-2789.
6. Jones BA, Davey DD. Quality management in gynecologic cytology using interlaboratory comparison. Arch Pathol Lab Med 2000; 124:672-681.
7. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA 1994; 271:1866-1869.
8. Dehner LP. Cervicovaginal cytology, false-negative results, and standards of practice. Am J Clin Pathol 1993; 99:45-47.
9. Gay JD, Donaldson LD, Goellner JR. False-negative results in cervical cytologic studies. Acta Cytol 1985; 29:1043-1046.
10. Dodd LG, Sneige N, Villarreal Y, et al. Quality-assurance study of simultaneously sampled, non-correlating cervical cytology and biopsies. Diagn Cytopathol 1993; 9:138-144.
11. McGoogan E, Reith A. Would monolayers provide more representative samples and improved preparations for cervical screening? Overview and evaluation of systems available. Acta Cytol 1996; 40:107-119.
12. Corkill M, Knapp D, Hutchinson ML. Improved accuracy for cervical cytology with the thin prep method and the endocervical brush-spatula collection procedure. Journal of Lower Genital Tract Disease 1998;2:12-16.
13. Lee KR, Ashfaq R, Birdsong GG, Corkill ME, McIntosh KM, Inhorn SL. Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening. Obstet Gynecol 1997; 90:278-284.
14. Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999; 281:1605-1610.
15. Nindl I, Lorincz A, Mielzynska I, et al. Human papillomavirus detection in cervical intraepithelial neoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods. Clin Diagn Virol 1998; 10:49-56.
16. Davey DD, Woodhouse S, Styer P, Stastny J, Mody D. Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the College of American Pathologists interlaboratory comparison program in cervicovaginal cytology. Arch Pathol Lab Med 2000; 124:203-211.
17. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287:2114-2119.
18. Stoler MH. New Bethesda terminology and evidence-based management guidelines for cervical cytology findings. JAMA 2002; 287:2140-2141.
19. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000; 92:397-402.
20. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001; 93:293-299.
21. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001; 285:1500-1505.
22. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287:2120-2129.
23. Sherman ME, Schiffman M, Cox JT. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 2002; 94:102-107.
24. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002; 52:342-362.
25. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347:1645-1651.